Now published! 'Identification of transporter-dependent capsular loci associated with the invasive potential of Escherichia coli' www.nature.com/articles/s41... insights below.....

Congrats @efosternyarko.bsky.social and team for this great work building capacity for public health genomics to investigate cholera and other enteric bacteria, across Africa 👏

www.lshtm.ac.uk/research/cen...

Quote card on dark blue background with a photograph of Dr Ebenn Foster-Nyarko on the right

New study led by Dr @efosternyarko.bsky.social in Microbial Genomics finds high antibiotic resistance in cholera bacteria across Africa.

Sequencing by PulseNet Africa trainees shows need for stronger genomic surveillance.

Read more: bit.ly/4aFMTyP

@lshtm.bsky.social @mrcunitgambia.bsky.social

Global Incidence of #Pertussis after the COVID-19 Pandemic - A large collaborative effort under the auspices of the International #Bordetella Society, led by Andrew Gorringe, from the UK Health Security Agency. jamanetwork.com/journals/jam...

New preprint finally out! So happy to share one of the latest studies from the #MedVetKlebs project, thanks to a great collaborative effort with @josefdelgadoblas.bsky.social, @sylvainbrisse.bsky.social, Elodie Barbier and Pascal Piveteau (INRAE) among others!

🧫 Our publication,“Global perspectives on Klebsiella epidemiology and biology: conference report on the KLEBS 2024 symposium,” is now out!

📄 Link to paper: www.nature.com/articles/s44...

@kelwyres.bsky.social @katholt.bsky.social @sylvainbrisse.bsky.social @pasteur.fr

No innocent bystanders: pertussis vaccination and evolutionary parallelisms between Bordetella parapertussis and Bordetella pertussis Pathogens adapting to the human host and to vaccination-induced immunity may follow parallel evolutionary paths. Bordetella parapertussis (Bpp) contributes significantly to the burden of whooping coug...

It’s out ! Evolution of Bordetella parapertussis, the second agent of whooping cough: many parallelisms with Bordetella pertussis, including rapid adaptation by loss of the pertactin vaccine antigen. Just published in @microbiosoc MGen journal
www.microbiologyresearch.org/content/jour...

Every hour counts in sepsis. Assistant Professor @mrcunitgambia.bsky.social and @lshtm.bsky.social UduakOkomo explains why timely care is key to saving lives.

Learn more with @jhenryc.bsky.social on the facts and actions to tackle sepsis.

Read more: bit.ly/3XBaTeS

Building local expertise is key to fighting AMR.

Our short course trains scientists and healthcare professionals from around the world.

Register your interest for 2026👉 bit.ly/4i4pokG

Antimicrobial Resistance Awareness Week starts today.

Our research themes show how we tackle AMR from every angle, from biological and clinical sciences to modelling, social science, and more.

Learn more: 👉 bit.ly/4i5Uf0v

#Klebsiella infections are a serious & growing #PublicHealth threat

For #AntimicrobialAwarenessWeek, @josebengoechea.bsky.social discusses the dangers of bacterial infections, antimicrobial resistance & the global efforts to tackle it. @lshtmamrcentre.bsky.social

www.lshtm.ac.uk/newsevents/e...

Contribution of nosocomial transmission to Klebsiella pneumoniae neonatal sepsis in Africa and South Asia: a meta-analysis of infection clusters inferred from pathogen genomics and temporal data www.medrxiv.org/content/10.1101/2025.11....

The @klebnet.bsky.social team are pleased to share slides from our “Klebsiella pneumoniae Genomic Epidemiology & Antimicrobial Resistance” lecture series!

Topics include Kleb diversity, lineages, AMR, hypervirulence, how to use Kaptive & Kleborate for typing, and more!

klebnet.org/2025/11/18/k...

Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: meta-analysis of genome-predicted serotype prevalence and potential vaccine coverage Background: Klebsiella pneumoniae causes ~20% of sepsis in neonates, with ~40% crude mortality. A vaccine administered to pregnant women, protecting against 70% of K. pneumoniae infections, could aver...

I'm super happy to share this preprint on ‘Distribution of capsule and O types in #Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: meta-analysis of genome-predicted serotype prevalence and potential vaccine coverage’
doi.org/10.1101/2025...

Honoured + super grateful to give an oral talk on efforts by #PulseNETAfrica to enhance capacity of public health labs across Africa for cholera mgt + a poster describing investigation of a neonatal kleb pneumoniae ST39 outbreak in a rural hospital in the Gambia at #IMMEM XIV in beautiful Porto 🇵🇹

✨Célia Souque just showcased the outcomes of the 12th Microbial Bioinformatics Hackathon at IMMEM XIV.

She brilliantly presented the first sneak-peek of PORT – Plasmid Outbreak Reporting Tool! 🧬
Looking forward to continuing this collaboration with PORT!

#IMMEM #Hackathon #Plasmids #ESGEM #ESGMAP

The words "INTRODUCING Sequity" and "Your Partner for Microbial Genomics" are shown with the Sequity logo. Above this text is an illustration of four people in a lab setting working with equipment and a laptop.

At the top there is a map of the world showing pins and illustrations of hospitals and laboratories. The text reads SEQUITY MAKES GENOMICS WORK FOR YOU Developing solutions that work with your unique lab, challenges and epidemiology CONTEXT-DRIVEN Delivering outcomes aligned with your objectives GOAL-ORIENTED

This image is text only. This reads, YOUR PARTNER FOR GENOMICS SUCCESS STRATEGY Figuring out what will work in your unique context RESOURCES Developing everything- from bioinformatics workflows to SOPs TRAINING Ensuring you have the knowledge and skills to deliver ON-DEMAND SUPPORT Ongoing support through the day-to-day

An abstract image at the bottom shows scientists working through a process, generating ideas. The text at the top reads, FROM IDEA TO IMPACT END-TO-END SUPPORT From study design to sample, wet lab, bioinformatic, and reporting VALUED-OUTCOMES Unlock information and real-world impact

I’ve got something exciting to share. After years of working with labs around the world, I’m starting something new!

I’ve seen how many labs want to do more with genomics, but the path forward isn’t always clear. The process is complex, and without the right guidance, it’s easy to get stuck.

Check out our tour-de-force study exploring Klebsiella capsules and O types in neonatal sepsis isolates from Asia & Africa. An excellent demonstration of how collaboration is essential to move the field forward & realise the benefits of genomics for public health & clinical micro!

Thanks for your kind words, support and encouragement every step of the way, @katholt.bsky.social!

Ebenezer Foster-Nyarko presenting his introductory slide on cholera genomics at the ABPHM 2025 conference

Super talk from @efosternyarko.bsky.social @lshtmamrcentre.bsky.social on nanopore based sequencing of cholera across Africa, with PulseNet Africa partners

#ABPHM25

www.biorxiv.org/content/10.1...

We are pleased to launch the KlebNET Genomic Epidemiology Consortium!

We aim to build a public metadata repository; systematic risk framework for global genomic surveillance; and genomic epi reviews for high-impact #Klebsiella clones.

Join us here:
klebnet.org/klebnet-gsp-...

#ABPHM25

You both were such amazing hosts - thanks for an excellent conference! 🎉

Thanks @sylvainbrisse.bsky.social for involving me in KlebNET-GSP as project manager 3y ago, it was a very enriching experience! Thanks to all the attendees of #KLEBS2024 for making this a great success, it was our best reward! And thanks to the @gatesfoundation.bsky.social for making it possible!

JOB ALERT!
Come work with me at LSHTM to investigate transmission of Klebsiella pneumoniae in neonatal units in Africa using bioinformatics and genomic epi.
Great team, Gates funded, £44-50k/yr, 1-year postdoc to start with possibilities to extend. Closing March 26.
jobs.lshtm.ac.uk/vacancy.aspx...